Physiomics – grant award it considers “a testimony to the innovative culture of our company”. Is it really though?…
By Steve Moore | Friday 10 November 2023
Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.
Stating that it offers cutting edge techniques and expertise to streamline drug development journeys, Physiomics (PYC) “is pleased to announce that it has been awarded a grant by Innovate UK and The Office for Life Sciences as part of the UK Government's Advancing Precision Medicine programme… we believe is a testimony to the innovative culture of our company”. Hmmm, what of a current share price of 1.6p then – down from above 5p early this year?
Premium content is for paid subscribers only
ShareProphets is reader-supported journalism
Become a member starting at £6.99 per month for all articles, the Bearcast, and our seven year archive.